Lista de obras - Hani Gabra - Dominio Público Uruguay

10th Biennial Helene Harris Memorial Trust Meeting

scientific article published on 01 March 2006

A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2017

A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer

scientific article published in Nature Communications

A method for voltage measurements of cancerous vs non-cancerous omentum

artículo científico publicado en 2015

A new network for translational research in ovarian cancer. Interview by Helen Saul.

artículo científico publicado en 2010

A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers.

artículo científico publicado en 2008

A prognostic model for ovarian cancer.

artículo científico publicado en 2001

A protective role for common p21WAF1/Cip1 polymorphisms in human ovarian cancer

artículo científico publicado en 1999

A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.

artículo científico publicado en 2015

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer.

artículo científico publicado en 2014

A statistical analysis of chromosome 11 and 17 loss of heterozygosity in epithelial ovarian cancer.

artículo científico publicado en 1996

A study of symptoms described by ovarian cancer survivors.

artículo científico publicado en 2011

A study to evaluate the cause of bone demineralization in gynecological cancer survivors.

artículo científico publicado en 2013

Adiposity and cancer at major anatomical sites: umbrella review of the literature

artículo científico publicado en 2017

An unusual case of sex cord tumor with annular tubules with malignant transformation in a patient with Peutz-Jeghers syndrome.

artículo científico publicado en 2010

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer

artículo científico publicado en 2018

Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study

artículo científico publicado en 2018

Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients

scientific article published on 01 June 2007

Back to the future: Targeting molecular changes for platinum resistance reversal.

artículo científico publicado en 2010

Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy

scientific article published on 03 May 2018

British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice

artículo científico publicado en 2017

CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup.

artículo científico publicado en 2002

Carcinosarcoma of the ovary: 19 years of prospective data from a single center.

artículo científico publicado en 2004

Cerebral sinus thrombosis and leptomeningeal carcinomatosis in a patient with ovarian cancer

scientific article published on 12 December 2011

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)

artículo científico publicado en 2018

Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population

artículo científico publicado en 2019

Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells.

artículo científico publicado en 2012

Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours ⬇️

artículo científico publicado el 1 de agosto de 1995

Clinical value of bioelectrical properties of cancerous tissue in advanced epithelial ovarian cancer patients

artículo científico publicado en 2018

Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells

artículo científico publicado en 2018

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Copy number signatures and mutational processes in ovarian carcinoma

artículo científico publicado en 2018

Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: A retrospective evaluation

artículo científico publicado en 2016

CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer

article

DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance.

artículo científico publicado en 2011

Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.

artículo científico publicado en 2013

Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker

artículo científico publicado en 2019

Dose density and altered scheduling of adjuvant chemotherapy in ovarian cancer: teaching old dogs new tricks?

artículo científico publicado en 2009

Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies.

artículo científico publicado en 2015

Drug-induced exacerbation of glomus tumour pain

scientific article published on 12 June 2006

Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2018

Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma

artículo científico publicado en 2021

Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.

artículo científico publicado en 2008

Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer

artículo científico publicado en 2007

Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus.

artículo científico publicado en 2007

Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer

artículo científico publicado en 2009

Feasibility of trials in ovarian cancer by line of therapy and platinum sensitivity.

artículo científico publicado en 2013

Foreword

Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.

artículo científico publicado en 2012

Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen

scientific article published on 01 September 1998

Future directions in the management of epithelial ovarian cancer.

artículo científico publicado en 2008

Gastrointestinal complications associated with the surgical treatment of heart disease in children.

artículo científico publicado en 2016

Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas

artículo científico publicado en 2011

HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.

artículo científico publicado en 2011

High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.

artículo científico publicado en 1996

High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.

artículo científico publicado en 1996

Homozygous deletions may be markers of nearby heterozygous mutations: The complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX.

artículo científico publicado en 2008

Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer

scientific article published on 01 June 1999

Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression.

artículo científico publicado en 2003

Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer.

artículo científico publicado en 2016

Immunological and gene therapy for ovarian cancer a technical overview.

artículo científico publicado en 2001

Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.

artículo científico publicado en 2017

In vitro effects of adriamycin: a dose-response study

scientific article published on 01 May 2007

Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions

scientific article published on 17 July 2019

Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer.

artículo científico publicado en 2010

Integrative analysis of subcellular quantitative proteomics studies reveals functional cytoskeleton membrane-lipid raft interactions in cancer.

artículo científico publicado en 2016

Intra-uterine death resulting from placental metastases in adenocarcinoma of unknown primary

artículo científico publicado en 2002

Introduction to managing patients with recurrent ovarian cancer

artículo científico publicado en 2014

LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression

artículo científico publicado en 2014

Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer

scientific article published on 01 September 1995

Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities.

artículo científico publicado en 2016

Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome

scientific article published on 26 June 2019

Metabonomic analysis of ovarian tumour cyst fluid by proton nuclear magnetic resonance spectroscopy

artículo científico publicado en 2016

Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.

artículo científico publicado en 2013

OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers.

artículo científico publicado en 2012

Obesity and gynaecological and obstetric conditions: umbrella review of the literature.

artículo científico publicado en 2017

Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management

artículo científico publicado en 2020

Ovarian cancer

scientific article published on 01 December 2002

Ovarian cancer

scientific article published on 01 December 2003

Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer

artículo científico publicado en 2016

Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer

artículo científico publicado en 2018

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

artículo científico publicado en 2004

Phase Ib study of the mitochondrial inhibitor ME-344 plus topotecan in patients with previously treated, locally advanced or metastatic small cell lung, ovarian and cervical cancers

artículo científico publicado en 2017

Plasma Kisspeptin: A Potential Biomarker of Tumor Metastasis in Patients with Ovarian Carcinoma

artículo científico publicado en 2012

Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer.

artículo científico publicado en 2011

Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification

scientific article published on 03 July 2019

Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer

artículo científico publicado en 2016

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

artículo científico publicado en 2015

Rethinking ovarian cancer: recommendations for improving outcomes

artículo científico publicado en 2011

Risk Factors for Endometrial Cancer: An umbrella review of the literature

artículo científico publicado en 2019

Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer.

artículo científico publicado en 2015

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.

artículo científico publicado en 2017

Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer

artículo científico publicado en 2012

Sexual activity and functioning in ovarian cancer survivors: an internet-based evaluation.

artículo científico publicado en 2014

Surgery for Recurrent Uterine Cancer: Surgical Outcomes and Implications for Survival-A Case Series.

artículo científico publicado en 2017

Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.

artículo científico publicado en 2011

TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition

scientific article published on 15 December 2016

The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.

artículo científico publicado en 2016

The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration

artículo científico publicado en 2010

The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer.

artículo científico publicado en 2017

The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer.

artículo científico publicado en 2002

The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future

artículo científico publicado en 2014

The next steps in improving the outcomes of advanced ovarian cancer.

artículo científico

The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma

artículo científico publicado en 2015

The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer

artículo científico publicado en 2018

Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective.

artículo científico publicado en 2017

Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.

artículo científico publicado en 2015

WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.

artículo científico publicado en 2009

WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear.

artículo científico publicado en 2005

WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response.

artículo científico publicado en 2017

WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis.

artículo científico publicado en 2010

Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study

artículo científico publicado en 2013

Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9

artículo científico publicado en 2012

[Effect of WWOX gene on the attachment and adhesion of ovarian cancer cells]

artículo científico publicado en 2009

c-myc oncogene expression in colorectal cancer

artículo científico publicado en 1987

Lista de obras de Hani Gabra

10th Biennial Helene Harris Memorial Trust Meeting

A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer.

A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer

A method for voltage measurements of cancerous vs non-cancerous omentum

A new network for translational research in ovarian cancer. Interview by Helen Saul.

A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers.

A prognostic model for ovarian cancer.

A protective role for common p21WAF1/Cip1 polymorphisms in human ovarian cancer

A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer.

A statistical analysis of chromosome 11 and 17 loss of heterozygosity in epithelial ovarian cancer.

A study of symptoms described by ovarian cancer survivors.

A study to evaluate the cause of bone demineralization in gynecological cancer survivors.

Adiposity and cancer at major anatomical sites: umbrella review of the literature

An unusual case of sex cord tumor with annular tubules with malignant transformation in a patient with Peutz-Jeghers syndrome.

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer

Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study

Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients

Back to the future: Targeting molecular changes for platinum resistance reversal.

Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy

British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice

CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup.

Carcinosarcoma of the ovary: 19 years of prospective data from a single center.

Cerebral sinus thrombosis and leptomeningeal carcinomatosis in a patient with ovarian cancer

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)

Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population

Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells.

Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours ⬇️

Clinical value of bioelectrical properties of cancerous tissue in advanced epithelial ovarian cancer patients

Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

Comprehensive Characterization of Cancer Driver Genes and Mutations

Copy number signatures and mutational processes in ovarian carcinoma

Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: A retrospective evaluation

CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer

DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance.

Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.

Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker

Dose density and altered scheduling of adjuvant chemotherapy in ovarian cancer: teaching old dogs new tricks?

Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies.

Drug-induced exacerbation of glomus tumour pain

Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer.

Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma

Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.

Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer

Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus.

Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer

Feasibility of trials in ovarian cancer by line of therapy and platinum sensitivity.

Foreword

Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.

Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen

Future directions in the management of epithelial ovarian cancer.

Gastrointestinal complications associated with the surgical treatment of heart disease in children.

Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas

HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.

High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.

High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.

Homozygous deletions may be markers of nearby heterozygous mutations: The complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX.

Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer

Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression.

Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer.

Immunological and gene therapy for ovarian cancer a technical overview.

Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.

In vitro effects of adriamycin: a dose-response study

Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions

Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer.

Integrative analysis of subcellular quantitative proteomics studies reveals functional cytoskeleton membrane-lipid raft interactions in cancer.

Intra-uterine death resulting from placental metastases in adenocarcinoma of unknown primary

Introduction to managing patients with recurrent ovarian cancer

LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression

Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer

Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities.

Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome

Metabonomic analysis of ovarian tumour cyst fluid by proton nuclear magnetic resonance spectroscopy

Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.

OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers.

Obesity and gynaecological and obstetric conditions: umbrella review of the literature.

Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management

Ovarian cancer